What fools these mortals be: The Tipline for 8 September 2020
We hope you all had a splendid three-day weekend. Before everyone logged off on Friday, the Federal Trade Commission announced that it approved a final order settling charges that AbbVie’s $63 billion acquisition of Allergan would violate federal antitrust law. Commissioner Rohit Chopra took another dig at the settlement, which he voted against back in May. “Public input received during the comment period from across the country also called into question the appropriateness of this decision, but the FTC went ahead anyway,” he tweeted.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10